Table 5.

Test results of the commercial HIV and TP panels

	SD Bioline HIV/Syphilis Duo	DPP HIV-Syphilis Assay	Multiplo Rapid TP/HIV Antibody Test	Insti Multiplex HIV-1/HIV-2/Syphilis Antibody Test
HIV seroconversion panel	HIV-1/2 antibodies were detected 0.125 specimens earlier compared to the reference assay	HIV-1/2 antibodies were detected 0.25 specimens later compared to the reference assay	HIV-1/2 antibodies were detected 0.125 specimens later compared to the reference assay	HIV-1/2 antibodies were detected at the same time as the reference assay
HIV mixed titre panels	All were correctly detected	88% were correctly detected (22/25; one false reactive, one false non-reactive and one indeterminate)	96% were correctly detected (24/25; one false non-reactive)	All were correctly detected
WHO HIV Reference preparations	All were correctly detected, with the exception of the Group O specimen (indeterminate)	All were correctly detected	All were correctly detected	All were correctly detected
TP seroconversion panels	TP antibodies were detected 2 specimens earlier compared to the reference assay	TP antibodies were detected at the same time compared to the reference assay	TP antibodies were detected 2 specimens later compared to the reference assay	TP antibodies were detected 1 specimen earlier compared to the reference assay
TP mixed titre panels	All were correctly detected	All were correctly detected	All were correctly detected	All were correctly detected
WHO TP Reference preparations	All were correctly detected	All were correctly detected	All were correctly detected	All were correctly detected